Next Article in Journal
CD109 Is a Critical Determinant of EGFR Expression and Signaling, and Tumorigenicity in Squamous Cell Carcinoma Cells
Next Article in Special Issue
Clinical Significance of Tumor Size in Gross Extrathyroidal Extension to Strap Muscles (T3b) in Papillary Thyroid Carcinoma: Comparison with T2
Previous Article in Journal
Precision Medicine of Hepatobiliary and Pancreatic Cancers: Focusing on Clinical Trial Outcomes
Previous Article in Special Issue
Is Gross Extrathyroidal Extension to Strap Muscles (T3b) Only a Risk Factor for Recurrence in Papillary Thyroid Carcinoma? A Propensity Score Matching Study
 
 
Article
Peer-Review Record

Central Lymph Node Ratio Predicts Recurrence in Patients with N1b Papillary Thyroid Carcinoma

Cancers 2022, 14(15), 3677; https://doi.org/10.3390/cancers14153677
by Il Ku Kang †, Kwangsoon Kim †, Joonseon Park, Ja Seong Bae * and Jeong Soo Kim
Reviewer 1: Anonymous
Reviewer 2:
Cancers 2022, 14(15), 3677; https://doi.org/10.3390/cancers14153677
Submission received: 24 June 2022 / Revised: 22 July 2022 / Accepted: 26 July 2022 / Published: 28 July 2022

Round 1

Reviewer 1 Report

Dear authors,

your study aim to investigate the relationship between LNR and disease-free survival (DFS) in PTC patients with lateral LN metastases (N1b PTC). This is an interesting paper, but some minor revisions are need before its publication in Cancer journal

Introduction: the introduction is too short, I suggest to deepen the topic by adding more recent evidence of literature.

Discussion: what are the limitations of this research? how these can be overcome?

Conclusions: the conclusions must be rewritten trying to better finalize the data of the research carried out.

.

 

Author Response

Please see the attachment

Author Response File: Author Response.docx

Reviewer 2 Report

This is a retrospective study evaluating the contribution of central and lateral neck compartment lymph node ratios for predicting outcomes for PTC. The study evaluated over 300 subjects and as such is smaller than some of the previous reports on similar issues. The lymph node ratios (LNR) reported vary minimally from previous reports but there is new information regarding the independent contributions of each nodal compartment.

The study is well designed and the manuscript is well written without any major or minor corrections needed.

Author Response

Please see the attachment

Author Response File: Author Response.docx

Reviewer 3 Report

The manuscript provides some additional data on prognostication in papillary thyroid carcinoma, particularly in the context of TNM staging system limitations.

The paper is well written. The data are well presented; the results are thoroughly discussed and justify the conclusions.

There are, however, a few issues to resolve before the manuscript's publication.

The LNR, CLNR and LLNR cut-off values applied by the authors should be justified. The authors have stated that the ROC analysis has been performed, and the appropriate parameters have been calculated - however, the results are not presented in the paper. Those results should be definitely included. 

The minor issues:

- the version of  the AJCC TNM staging system should be added (lines 42-43)

- line 86: histological should be changed to cytological (as the FNAB was performed to confirm neck recurrence)

- line 215: predicative should be changed to predictive.

Author Response

Please see the attachment

Author Response File: Author Response.docx

Back to TopTop